Joel S. Ross M.D. – Cogwellin
Cogwellin, LLC
By working closely the pharmaceutical industry and the Food and Drug Administration Dr. Ross has conducted over 120 clinical trials the most state of the art diagnostic and therapeutic intervention testing the latest medications under development.
Dr. Ross has been Principal Investigator or Sub-investigator evaluating nearly every medication tested for Alzheimer’s disease in clinical trials since 1994 including the currently four FDA approved medications: Aricept/Exelon/Razadyne and Namenda. Dr. Ross has conducted over 120 research protocols as the Principal Investigator or subinvestigator. He has lectured worldwide. Dr. Ross received his medical degree from Downstate Medical Center, Brooklyn, New York, where he graduated Cum Laude. He completed his internship and residency at Nassau County Medical Center, in East Meadow, New York, where he then became Chief Resident. He is certified in Geriatric Medicine, Internal Medicine and a Certified Physician Investigator by the Association of Clinical Research Professionals. He was the founding member of the geriatric fellowship program at Jersey Shore Medical University and in 2000 was recognized as an “advocate for excellence” as program director-Geriatric Residency at Jersey Shore Medical University. Dr. Ross was awarded the “top doctor” in the field of Geriatric Medicine in New Jersey by his peers.
Dr. Ross received the Humanitarian of Year Award in 2011 from the Alzheimer ’s disease Caregivers of Central NJ.
Dr. Ross is a former trustee of the Association of Clinical Research Professionals as well as served on the scientific advisory board of the Alzheimer’s Drug Discovery Foundation.
